Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
Purity:
99.49%
CAS Number:
[1648796-29-5]
Target:
SARS-CoV|||c-Fms
* VAT and and shipping costs not included. Errors and price changes excepted